CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT

Aim. Increase of efficiency of pharmacological correction of hypertensive neuroretinopathy using a new dimethylaminoethanol (DMAE) derivative 7-16.Materials and methods. Modeling of hypertensive neuroretinopathy was carried out by introducing a nonselective inhibitor of NO-synthase N-nitro-L-arginin...

Full description

Bibliographic Details
Main Authors: A. A. PERESYPKINA, M. V. POKROVSKII, V. O. GUBAREVA, E. A. LEVKOVA
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2018-02-01
Series:Кубанский научный медицинский вестник
Subjects:
Online Access:https://ksma.elpub.ru/jour/article/view/1014
_version_ 1797295482044678144
author A. A. PERESYPKINA
M. V. POKROVSKII
V. O. GUBAREVA
E. A. LEVKOVA
author_facet A. A. PERESYPKINA
M. V. POKROVSKII
V. O. GUBAREVA
E. A. LEVKOVA
author_sort A. A. PERESYPKINA
collection DOAJ
description Aim. Increase of efficiency of pharmacological correction of hypertensive neuroretinopathy using a new dimethylaminoethanol (DMAE) derivative 7-16.Materials and methods. Modeling of hypertensive neuroretinopathy was carried out by introducing a nonselective inhibitor of NO-synthase N-nitro-L-arginine-methyl ester in a dose 12.5 mg/kg within 28 days and increasing intraocular pressure to 110 mm Hg by exerting mechanical pressure on the anterior chamber of the eye. To study the fundus of experimental animals, direct ophthalmoscopy (ophthalmoscope Bx a Neitz, Japan) was used. To zoom a lens Osher MaxField 78D model OI-78M has been used. Electroretinography was performed immediately after ophthalmoscopy. The ERG was recorded in response to a single stimulation. The induced biopotentials were amplified, averaged and presented graphically on the screen with the help of Biopac-systems MP-150 with the program AcqKnowledge 4.2 (USA). To assess the degree of development of functional damage to the retina, the ratio of the amplitudes of the b- and a-waves of the ERG, the coefficient b/a, was estimated.Results. The expressed protective properties of the DMAE derivative 7-16 in a dose 25 mg/kg/day, exceeding its effect in a dose 12.5 mg/kg/day, were found, which resulted in a decrease of development of neuronal damage and vascular changes in the retina on the background of hypertension, which were noted in control group; an increase in the coefficient b/a in groups with the correction of pathology, which is caused by the restoration of the positive wave b on the ERG and indicates the preservation of the electrophysiological function of the bipolar and Müllerian cells.Conclusion. The search of new ways to reduce the damaging effect of ischemia formed in hypertensive neuroretinopathy in the experiment is a vital task of pharmacology, which can be solved by using a new DMAE derivative 7-16.
first_indexed 2024-03-07T21:48:34Z
format Article
id doaj.art-7bf978d102f347abaf0836b47691adf6
institution Directory Open Access Journal
issn 1608-6228
2541-9544
language Russian
last_indexed 2024-03-07T21:48:34Z
publishDate 2018-02-01
publisher Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
record_format Article
series Кубанский научный медицинский вестник
spelling doaj.art-7bf978d102f347abaf0836b47691adf62024-02-25T10:57:21ZrusMinistry of Healthcare of the Russian Federation. “Kuban State Medical University”Кубанский научный медицинский вестник1608-62282541-95442018-02-0125110310710.25207/1608-6228-2018-25-1-103-107878CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENTA. A. PERESYPKINA0M. V. POKROVSKII1V. O. GUBAREVA2E. A. LEVKOVA3Federal State Autonomous Educational Institution of Higher Education Belgorod State National Research University.Federal State Autonomous Educational Institution of Higher Education Belgorod State National Research University.Federal State Autonomous Educational Institution of Higher Education Belgorod State National Research University.Federal State Autonomous Educational Institution of Higher Education Belgorod State National Research University.Aim. Increase of efficiency of pharmacological correction of hypertensive neuroretinopathy using a new dimethylaminoethanol (DMAE) derivative 7-16.Materials and methods. Modeling of hypertensive neuroretinopathy was carried out by introducing a nonselective inhibitor of NO-synthase N-nitro-L-arginine-methyl ester in a dose 12.5 mg/kg within 28 days and increasing intraocular pressure to 110 mm Hg by exerting mechanical pressure on the anterior chamber of the eye. To study the fundus of experimental animals, direct ophthalmoscopy (ophthalmoscope Bx a Neitz, Japan) was used. To zoom a lens Osher MaxField 78D model OI-78M has been used. Electroretinography was performed immediately after ophthalmoscopy. The ERG was recorded in response to a single stimulation. The induced biopotentials were amplified, averaged and presented graphically on the screen with the help of Biopac-systems MP-150 with the program AcqKnowledge 4.2 (USA). To assess the degree of development of functional damage to the retina, the ratio of the amplitudes of the b- and a-waves of the ERG, the coefficient b/a, was estimated.Results. The expressed protective properties of the DMAE derivative 7-16 in a dose 25 mg/kg/day, exceeding its effect in a dose 12.5 mg/kg/day, were found, which resulted in a decrease of development of neuronal damage and vascular changes in the retina on the background of hypertension, which were noted in control group; an increase in the coefficient b/a in groups with the correction of pathology, which is caused by the restoration of the positive wave b on the ERG and indicates the preservation of the electrophysiological function of the bipolar and Müllerian cells.Conclusion. The search of new ways to reduce the damaging effect of ischemia formed in hypertensive neuroretinopathy in the experiment is a vital task of pharmacology, which can be solved by using a new DMAE derivative 7-16.https://ksma.elpub.ru/jour/article/view/1014dimethylaminoethanolhypertensive neuroretinopathyelectroretinography
spellingShingle A. A. PERESYPKINA
M. V. POKROVSKII
V. O. GUBAREVA
E. A. LEVKOVA
CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
Кубанский научный медицинский вестник
dimethylaminoethanol
hypertensive neuroretinopathy
electroretinography
title CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
title_full CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
title_fullStr CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
title_full_unstemmed CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
title_short CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
title_sort correction of hypertensive neuroretinopathy by dimethylaminoethanol derivative 7 16 in experiment
topic dimethylaminoethanol
hypertensive neuroretinopathy
electroretinography
url https://ksma.elpub.ru/jour/article/view/1014
work_keys_str_mv AT aaperesypkina correctionofhypertensiveneuroretinopathybydimethylaminoethanolderivative716inexperiment
AT mvpokrovskii correctionofhypertensiveneuroretinopathybydimethylaminoethanolderivative716inexperiment
AT vogubareva correctionofhypertensiveneuroretinopathybydimethylaminoethanolderivative716inexperiment
AT ealevkova correctionofhypertensiveneuroretinopathybydimethylaminoethanolderivative716inexperiment